KAREN HERNANDEZ: Open Payments
NPI 1427284413 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 62 payments from 19 companies in 2025. Trend: 2023 $402 · 2024 $1,663 · 2025 $1,939
Food & beverage: $1,862Education: $77
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $491 |
| AstraZeneca Pharmaceuticals LP | 5 | $327 |
| PFIZER INC. | 8 | $174 |
| TerSera Therapeutics LLC | 5 | $156 |
| Genentech, Inc. | 1 | $132 |
| Lilly USA, LLC | 7 | $130 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Genentech USA, Inc. | 3 | $65 |
| Janssen Biotech, Inc. | 2 | $50 |
Products named: Enhertu, Itovebi, Zoladex, IBRANCE, VERZENIO, KEYTRUDA, KISQALI, MI CANCER SEEK.
Industry payments across FL — which companies pay providers there.
